Kilitch Drugs (India) Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 365.57 million compared to INR 334.53 million a year ago. Revenue was INR 371.2 million compared to INR 344.24 million a year ago.

Net income was INR 33.57 million compared to INR 20.86 million a year ago. Basic earnings per share from continuing operations was INR 2.15 compared to INR 1.34 a year ago. Diluted earnings per share from continuing operations was INR 2.15 compared to INR 1.34 a year ago.